{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:28:52Z","timestamp":1790418532066,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["KL2 TR000136"],"award-info":[{"award-number":["KL2 TR000136"]}],"id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jhep.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T18:52:22Z","timestamp":1528397542000},"page":"736-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Hepatic manifestations of telomere biology disorders"],"prefix":"10.1016","volume":"69","author":[{"given":"Mrinal M.","family":"Patnaik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Simonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2018.05.006_b0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev.genet.41.110306.130350","article-title":"How shelterin protects mammalian telomeres","volume":"42","author":"Palm","year":"2008","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.jhep.2018.05.006_b0010","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/nm1006-1133","article-title":"Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging","volume":"12","author":"Blackburn","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2018.05.006_b0015","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hep.20308","article-title":"Telomeres and telomerase: a dual role in hepatocarcinogenesis","volume":"40","author":"Satyanarayana","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.006_b0020","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1001\/jama.289.22.3000","article-title":"Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis","volume":"289","author":"Clark","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2018.05.006_b0025","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2004.02.013","article-title":"The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease","volume":"40","author":"Caldwell","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.05.006_b0030","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","article-title":"Dyskeratosis congenita in all its forms","volume":"110","author":"Dokal","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jhep.2018.05.006_b0035","doi-asserted-by":"crossref","first-page":"15960","DOI":"10.1073\/pnas.0508124102","article-title":"Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita","volume":"102","author":"Armanios","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2018.05.006_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007926","article-title":"A spectrum of severe familial liver disorders associate with telomerase mutations","volume":"4","author":"Calado","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2018.05.006_b0045","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/hep.24217","article-title":"Telomerase gene mutations are associated with cirrhosis formation","volume":"53","author":"Hartmann","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.006_b0050","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/hep.24173","article-title":"Constitutional telomerase mutations are genetic risk factors for cirrhosis","volume":"53","author":"Calado","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.006_b0055","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1096\/fj.01-0977com","article-title":"Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis","volume":"16","author":"Wiemann","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2018.05.006_b0060","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.287.5456.1253","article-title":"Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery","volume":"287","author":"Rudolph","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jhep.2018.05.006_b0065","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules","volume":"11","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.006_b0070","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/0002-9343(81)90828-7","article-title":"Nodular regenerative hyperplasia of the liver associated with macroglobulinemia. A clue to the pathogenesis","volume":"70","author":"Wanless","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2018.05.006_b0075","first-page":"133","article-title":"Nodular regenerative hyperplasia of the liver associated with polyarteritis nodosa","volume":"108","author":"Nakanuma","year":"1984","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jhep.2018.05.006_b0080","first-page":"838","article-title":"Nodular regenerative hyperplasia of the liver in a patient with rheumatoid vasculitis: a morphometric study suggesting a role for hepatic arteritis in the pathogenesis","volume":"11","author":"Reynolds","year":"1984","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jhep.2018.05.006_b0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00005792-198009000-00004","article-title":"Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis","volume":"59","author":"Wanless","year":"1980","journal-title":"Medicine"},{"key":"10.1016\/j.jhep.2018.05.006_b0090","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hep.20571","article-title":"Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice","volume":"41","author":"Croquelois","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.006_b0095","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/hep.28713","article-title":"Endothelial notch signaling is essential to prevent hepatic vascular malformations in mice","volume":"64","author":"Cuervo","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.006_b0100","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/liv.12261","article-title":"Downregulation of the endothelial genes Notch1 and ephrinB2 in patients with nodular regenerative hyperplasia","volume":"34","author":"Rothweiler","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2018.05.006_b0105","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ajmg.a.30724","article-title":"Adams-Oliver syndrome and hepatoportal sclerosis: occasional association or common mechanism?","volume":"135","author":"Girard","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jhep.2018.05.006_b0110","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1378\/chest.15-0825","article-title":"Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders","volume":"148","author":"Gorgy","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.jhep.2018.05.006_b0115","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1172\/JCI90338","article-title":"Long telomeres protect against age-dependent cardiac disease caused by NOTCH1 haploinsufficiency","volume":"127","author":"Theodoris","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2018.05.006_b0120","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1665-2681(19)32002-2","article-title":"Nodular regenerative hyperplasia associated to aplastic anemia: a case report and literature review","volume":"5","author":"Gonzalez-Huezo","year":"2006","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2018.05.006_b0125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/thx.2008.099796","article-title":"Familial idiopathic pulmonary fibrosis in association with bone marrow hypoplasia and hepatic nodular regenerative hyperplasia: a new \u201ctrimorphic\u201d syndrome","volume":"64","author":"Talbot-Smith","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.jhep.2018.05.006_b0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/gut.51.2.275","article-title":"Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients","volume":"51","author":"Hillaire","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2018.05.006_b0135","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1023\/A:1022549018807","article-title":"Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients","volume":"48","author":"Kaymakoglu","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2018.05.006_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120299","article-title":"Diagnosing nodular regenerative hyperplasia of the liver is thwarted by low interobserver agreement","volume":"10","author":"Jharap","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2018.05.006_b0145","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/lt.20431","article-title":"Liver transplantation for severe intrahepatic noncirrhotic portal hypertension","volume":"11","author":"Krasinskas","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.05.006_b0150","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1002\/hep.26904","article-title":"Idiopathic portal hypertension: natural history and long-term outcome","volume":"59","author":"Siramolpiwat","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.006_b0155","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1365-2036.2012.05112.x","article-title":"Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study","volume":"35","author":"Schouten","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2018.05.006_b0160","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2559.2010.03511.x","article-title":"Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis","volume":"56","author":"Rubbia-Brandt","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.jhep.2018.05.006_b0165","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/lt.21417","article-title":"Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia","volume":"14","author":"Mitchell","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.05.006_b0170","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2012.250","article-title":"Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output","volume":"307","author":"Dupuis-Girod","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2018.05.006_b0175","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.ophtha.2017.01.044","article-title":"Exudative vitreoretinopathy in dyskeratosis congenita","volume":"124","author":"Indaram","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jhep.2018.05.006_b0180","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00417-008-0949-6","article-title":"Rapid regression of retinal hemorrhage and neovascularization in a case of familial exudative vitreoretinopathy treated with intravitreal bevacizumab","volume":"246","author":"Tagami","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jhep.2018.05.006_b0185","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.dld.2011.04.004","article-title":"Liver transplantation for the treatment of nodular regenerative hyperplasia","volume":"43","author":"Manzia","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2018.05.006_b0190","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jceh.2015.10.003","article-title":"Liver transplantation after bone marrow transplantation for end stage liver disease with severe hepatopulmonary syndrome in dyskeratosis congenita: a literature first","volume":"5","author":"Mahansaria","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jhep.2018.05.006_b0195","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O","article-title":"Telomere length measurements using digital fluorescence microscopy","volume":"36","author":"Poon","year":"1999","journal-title":"Cytometry"},{"key":"10.1016\/j.jhep.2018.05.006_b0200","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/cyto.a.20006","article-title":"Telomere length assessment in tissue sections by quantitative FISH: image analysis algorithms","volume":"58","author":"O'Sullivan","year":"2004","journal-title":"Cytometry A"},{"key":"10.1016\/j.jhep.2018.05.006_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092559","article-title":"Telomere Q-PNA-FISH\u2013reliable results from stochastic signals","volume":"9","author":"Cukusic Kalajzic","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2018.05.006_b0210","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2144\/000112761","article-title":"A quantitative real-time PCR method for absolute telomere length","volume":"44","author":"O'Callaghan","year":"2008","journal-title":"Biotechniques"},{"key":"10.1016\/j.jhep.2018.05.006_b0215","first-page":"E1906","article-title":"Robust measurement of telomere length in single cells","volume":"110","author":"Wang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2018.05.006_b0220","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1038\/srep06977","article-title":"Assessing telomere length using surface enhanced Raman scattering","volume":"4","author":"Zong","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2018.05.006_b0225","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/clinchem\/45.10.1718","article-title":"Simple, rapid, quantitative, and sensitive detection of telomere repeats in cell lysate by a hybridization protection assay","volume":"45","author":"Nakamura","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.jhep.2018.05.006_b0230","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/nprot.2010.124","article-title":"Measurement of telomere length by the Southern blot analysis of terminal restriction fragment lengths","volume":"5","author":"Kimura","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jhep.2018.05.006_b0235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mrfmmm.2011.04.003","article-title":"Telomere length measurement-caveats and a critical assessment of the available technologies and tools","volume":"730","author":"Aubert","year":"2012","journal-title":"Mutat Res"},{"key":"10.1016\/j.jhep.2018.05.006_b0240","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/nprot.2006.263","article-title":"Flow cytometry and FISH to measure the average length of telomeres (flow FISH)","volume":"1","author":"Baerlocher","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jhep.2018.05.006_b0245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng0598-32","article-title":"X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions","volume":"19","author":"Heiss","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2018.05.006_b0250","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1056\/NEJMc1206730","article-title":"Telomerase mutations and the pulmonary fibrosis-bone marrow failure syndrome complex","volume":"367","author":"Armanios","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.05.006_b0255","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mrfmmm.2011.10.013","article-title":"Telomerase and idiopathic pulmonary fibrosis","volume":"730","author":"Armanios","year":"2012","journal-title":"Mutat Res"},{"key":"10.1016\/j.jhep.2018.05.006_b0260","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1182\/blood-2014-05-526285","article-title":"Bone marrow failure and the telomeropathies","volume":"124","author":"Townsley","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2018.05.006_b0265","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood-2005-07-2622","article-title":"Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation","volume":"107","author":"Vulliamy","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2018.05.006_b0270","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ajhg.2007.10.004","article-title":"TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita","volume":"82","author":"Savage","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jhep.2018.05.006_b0275","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/hmg\/ddm111","article-title":"Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10","volume":"16","author":"Walne","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jhep.2018.05.006_b0280","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1073\/pnas.0800042105","article-title":"Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita","volume":"105","author":"Vulliamy","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2018.05.006_b0285","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1101\/gad.2006411","article-title":"Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita","volume":"25","author":"Zhong","year":"2011","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhep.2018.05.006_b0290","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2012.09.011","article-title":"Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis","volume":"58","author":"Valenti","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.05.006_b0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010680","article-title":"Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations","volume":"5","author":"Diaz de Leon","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2018.05.006_b0300","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.26089","article-title":"Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: a clue to telomere involvement","volume":"56","author":"Carulli","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.006_b0305","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/blood.V53.3.504.504","article-title":"A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia","volume":"53","author":"Camitta","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2018.05.006_b0310","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0002-9343(81)90204-7","article-title":"Long-term follow-up in patients with aplastic anemia. A study of 137 androgen-treated patients surviving more than two years. Joint Group for the Study of Aplastic and Refractory Anemias","volume":"71","author":"Najean","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2018.05.006_b0315","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00277-011-1163-x","article-title":"Danazol as first-line therapy for aplastic anemia","volume":"90","author":"Jaime-Perez","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jhep.2018.05.006_b0320","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF01707279","article-title":"Treatment of severe aplastic anemia with antilymphocyte globulin and androgens: a report on 33 patients","volume":"63","author":"Facon","year":"1991","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jhep.2018.05.006_b0325","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3324\/haematol.2015.129239","article-title":"Therapeutic effect of androgen therapy in a mouse model of aplastic anemia produced by short telomeres","volume":"100","author":"Bar","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jhep.2018.05.006_b0330","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mce.2005.05.009","article-title":"Hormones and growth factors regulate telomerase activity in ageing and cancer","volume":"240","author":"Bayne","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jhep.2018.05.006_b0335","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1182\/blood-2014-08-596445","article-title":"Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1","volume":"124","author":"Guo","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2018.05.006_b0340","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJMoa1515319","article-title":"Danazol treatment for telomere diseases","volume":"374","author":"Townsley","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.05.006_b0345","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/bjh.12748","article-title":"Response to androgen therapy in patients with dyskeratosis congenita","volume":"165","author":"Khincha","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jhep.2018.05.006_b0350","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/j.1572-0241.2002.05826.x","article-title":"Anabolic-androgenic steroids for alcoholic liver disease: a Cochrane review","volume":"97","author":"Rambaldi","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.05.006_b0355","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jhep.2016.06.007","article-title":"Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: a randomised controlled trial","volume":"65","author":"Sinclair","year":"2016","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882781832052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882781832052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:35:14Z","timestamp":1759174514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882781832052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S016882781832052X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2018.05.006","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic manifestations of telomere biology disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}